| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 06/29/2004 | US6756376 Preventing fatty acid release |
| 06/29/2004 | US6756375 Estrogen receptor modulation; hormone replacement therapy |
| 06/29/2004 | US6756372 For therapy of autoimmune diseases, alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, crohn's disease, ulcerative colitis, multiple sclerosis, guillain-barre syndrome, psoriasis |
| 06/29/2004 | US6756371 Morpholino or thiomorpholino derivatives; respiratory system disorders |
| 06/29/2004 | US6756362 Anionic polymers including dermatan sulfate, chondroitin sulfate, keratan sulfate, heparan sulfate, heparin, dextran sulfate, pentosan polysulfate, hyaluronic acid and alginate. |
| 06/24/2004 | WO2004052910A1 A full-length polynucleotide coding chicken type ii collagen and the use of it |
| 06/24/2004 | WO2004052888A2 Tropane esters and methods for producing and using them |
| 06/24/2004 | WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators |
| 06/24/2004 | WO2004052356A1 Composition for the treatment of pain, especially for the treatment of articular pain |
| 06/24/2004 | WO2004052286A2 Tyrosine kinase inhibitors |
| 06/24/2004 | WO2004052120A1 A healthy food for increasing bone density and anti-aging |
| 06/24/2004 | WO2004041862A3 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 06/24/2004 | WO2004024060A3 Metalloproteinase inhibitors and intermediates for preparation thereof |
| 06/24/2004 | WO2004022716A3 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 06/24/2004 | WO2004014304A3 Electrospun amorphous pharmaceutical compositions |
| 06/24/2004 | WO2004006834A3 Leflunomide analogs for treating rheumatoid arthritis |
| 06/24/2004 | WO2003103583A3 A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system |
| 06/24/2004 | WO2003099221A3 Methods for using jnk inhibitors for treating or preventing disease-related wasting |
| 06/24/2004 | WO2003092580B1 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 06/24/2004 | WO2003086311A3 Methods for treating tweak-related conditions |
| 06/24/2004 | WO2003018044A8 New drug |
| 06/24/2004 | WO2003014309A3 Interleukin-1 receptors in the treatment of diseases |
| 06/24/2004 | WO2002092594A8 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 06/24/2004 | US20040122254 Selective cyclooxygenase-2(COX-2) inhibitors; free of gastrointestinal side effects; treating eye disorders such as glaucoma or selective cyclooxygenase-2(COX-2) inhibitors, rheumatoid arthritis, arthritis, pain, inflammation |
| 06/24/2004 | US20040122052 Isoindolin-1-one and Isoindoline-1,3-dione substituted in the 2-position with a 2,6-dioxo-3-hydroxypiperidin-5-yl group or derivative; selectively inhibit TNF alpha, useful in treating inflammation and effecting relaxation of airway smooth muscle |
| 06/24/2004 | US20040122047 Substituted tetrahydroisoquinolines |
| 06/24/2004 | US20040122039 Pyrazolo[1,5-a]pyridines and medicines containing the same |
| 06/24/2004 | US20040122035 selective inhibitors of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase-5 (PDE5); sexual disorders, cardiovascular disorders; 1-(2H-benzo[d]1,3-dioxolan-5-yl)(1,2,3,4-tetrahydro- beta -carbolin-2-yl)-2-naphthyl ketone for example |
| 06/24/2004 | US20040122030 Substituted phthalimide and isoquinoline derivatives; thalidomide analogs that lack the piperidine-2,6-dione moiety of thalidomide |
| 06/24/2004 | US20040122025 4-(4-Fluorophenyl)-3-(2-methylsulfanyl-pyrimidin-4-yl)-2H-isoxazol-5-one for example; treating rheumatoid arthritis, osteoarthritis and congestive heart failure |
| 06/24/2004 | US20040122020 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity |
| 06/24/2004 | US20040121956 For therapy of diseases in animals and for the control of insects that are injurious or harmful to plants or animals |
| 06/24/2004 | US20040121345 Identification of a human n-terminal acetyltransferase gene |
| 06/24/2004 | US20040121028 Plant based agents as bioavailability / bioefficacy enhancers for drugs and nutraceuticals |
| 06/24/2004 | US20040120922 Method for promoting bone formation |
| 06/23/2004 | EP1431310A1 RECOMBINANT ANTI−OSTEOPONTIN ANTIBODY AND USE THEREOF |
| 06/23/2004 | EP1431293A1 Water-soluble phenylpyridazine derivatives and drugs containing the same |
| 06/23/2004 | EP1431285A1 Reverse hydroxamic acid derivatives |
| 06/23/2004 | EP1430894A1 Lymphocytic activation inhibitor and remedial agent for autoimmune disease |
| 06/23/2004 | EP1430891A1 Oil-acid-emulsion for the treatment of joint diseases and for the stimulation of blood-circulation |
| 06/23/2004 | EP1430144A2 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER |
| 06/23/2004 | EP1430126A1 Dna sequences for human angiogenesis genes |
| 06/23/2004 | EP1430080A2 Genetic sequences related to bone diseases in the osteopetrotic grey-lethal (gl) mouse |
| 06/23/2004 | EP1430056A1 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido 1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo 1,2-a]pyrimidin-5(1h)one derivatives for neurodegenerative disorders |
| 06/23/2004 | EP1430053A1 Chemical compounds |
| 06/23/2004 | EP1430048A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 06/23/2004 | EP1430041A2 Novel sulfonic acid derivatives |
| 06/23/2004 | EP1430027A2 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives |
| 06/23/2004 | EP1430026A1 3-desoxy-vitamin d3 analog esters |
| 06/23/2004 | EP1430020A1 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them |
| 06/23/2004 | EP1429817A1 Porous ceramic composite bone grafts |
| 06/23/2004 | EP1429796A2 Peptide antiangiogenic drugs |
| 06/23/2004 | EP1429784A2 High throughput screening assays using fatty acid synthetic enzymes |
| 06/23/2004 | EP1429782A1 Modulation of vitamin storage |
| 06/23/2004 | EP1429779A2 Androstanes as androgen receptor modulators |
| 06/23/2004 | EP1429773A1 Process for making substituted pyrazoles |
| 06/23/2004 | EP1429772A1 N-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl)pyrazole |
| 06/23/2004 | EP1429767A1 Acylic piperazine and piperidine derivatives which are useful for treating neuronal damage |
| 06/23/2004 | EP1429760A1 Novel combination |
| 06/23/2004 | EP1429727A1 Apoptosis-mimicking synthetic entities and use thereof in medical treatment |
| 06/23/2004 | EP1429617A2 Methods for sterilizing preparations of digestive enzymes |
| 06/23/2004 | EP1252157B1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 06/23/2004 | EP1251848B1 Gyrase inhibitors and uses thereof |
| 06/23/2004 | EP1237851A4 SALTS OF i Cis /i -4-CYANO-4- 3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]CYCLOHEXANE-1-CARBOXYLIC ACID |
| 06/23/2004 | EP1230227B1 Benzoxa-and benzothiazolyl sulfamates and their use as steroid sulfatase inhibitors |
| 06/23/2004 | EP1036075B1 Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypolipidemia and antihypertensive properties |
| 06/23/2004 | EP0977576B1 Osteoblast-promoting pharmaceutical composition comprising a carnitine compound and dhea or dhea-s |
| 06/23/2004 | EP0966424B1 Aminobenzophenones as inhibitors of interleukin and tnf |
| 06/23/2004 | EP0871471B1 Compositions using morphogenic proteins and stimulatory factors |
| 06/23/2004 | CN1507450A Novel cyclo azaphospha hydrocarbons |
| 06/23/2004 | CN1507444A 2,3-diazanaphthalene derivatives with angiogenesis inhibiting activity |
| 06/23/2004 | CN1507437A Aralkylpiperazines with serotonin 5-HTIA activity |
| 06/23/2004 | CN1507434A Novel 4-anilinoquinoline-3-carboxamides compound |
| 06/23/2004 | CN1507354A Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 06/23/2004 | CN1507348A Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders |
| 06/23/2004 | CN1506365A Prepn process of tripterygium extractive |
| 06/23/2004 | CN1506360A Method of extracting effective components in kudzu vine root |
| 06/23/2004 | CN1506116A Process for preparing degradable polymer and medical composition containing the said polymer and use thereof |
| 06/23/2004 | CN1506099A Chinese medicine for treating gout |
| 06/23/2004 | CN1506091A Plaster for treating rheumatic osteodynia |
| 06/23/2004 | CN1506065A Cell growth regulating factor D and its prepn process |
| 06/23/2004 | CN1506064A Cell growth regulating factor E and its prepn process |
| 06/23/2004 | CN1506052A Cell growth regulating factor X and its prepn process |
| 06/23/2004 | CN1154632C Amino alcohol derivs, method of producing said derivs, and medicaments contg. them |
| 06/23/2004 | CN1154508C Stimulation of host defence mechanisms against viral challenges |
| 06/23/2004 | CN1154507C Inhibition of binding of Hox and homeodomain containing proteins and uses thereof |
| 06/23/2004 | CN1154501C Substance for preparing medicine to promote union of bone fracture and its preparing process |
| 06/23/2004 | CN1154498C Process for preparation of oral pharmaceutical compositions comprising biphosphonates |
| 06/23/2004 | CN1154490C Celecoxib compositions |
| 06/22/2004 | US6753340 Autoimmune disease, antiarthritic agents, antiallergens, anticancer agents |
| 06/22/2004 | US6753335 Delta agonists for nervous system pain |
| 06/22/2004 | US6753332 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 06/22/2004 | US6753325 Comprises vitamin d3 for controlling cell differentiation and/or cell proliferation |
| 06/17/2004 | WO2004050660A1 Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
| 06/17/2004 | WO2004050656A1 1,3-dihydroimidazole fused-ring compound |
| 06/17/2004 | WO2004050118A1 Cysteine protease inhibitor |
| 06/17/2004 | WO2004050116A1 Protease inhibitor |
| 06/17/2004 | WO2004050103A1 Replacement joint fluid |
| 06/17/2004 | WO2004050086A1 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 06/17/2004 | WO2004050078A1 Remedy |